Increased risk of second malignant neoplasms in adolescents and young adults with cancer
Open Access
Abstract
BACKGROUND: The authors describe the incidence and characteristics of secondary malignant neoplasms (SMNs) in adolescent and young adult (AYA) cancer survivors compared with those in younger and older cancer survivors.METHODS: Children aged ≤14 years, AYAs aged 15 to 39, and older adults aged ≥40 years at the time of primary diagnosis who were reported as cancer survivors in the Surveillance, Epidemiology, and End Results (SEER) program between 1973 and 2011 were compared in this population‐based analysis. The primary analysis was the risk that an SMN would occur ≥5 years after the original diagnosis for patients who had the more common AYA cancers (leukemia, lymphoma, testicular malignancy, ovarian malignancy, melanoma, and cancers of the thyroid, breast, soft tissue, or bone). The standardized incidence ratio (SIR), absolute excess risk (AER), and cumulative incidence of SMN for the selected cancers were assessed. The risk of SMN for the entire cohort also was analyzed.RESULTS: Of the 148,558 AYA survivors who were diagnosed with a selected cancer, 7384 developed an SMN 5 years after their original diagnosis. The SIRs (95% confidence intervals [CIs]) were 1.58 (95% CI, 1.55‐1.62) for AYAs, 4.26 (95% CI, 3.77‐4.80) for children, and 1.10 (95% CI, 1.09‐1.11) for older adults, and the AERs were 22.9, 16.6, and 14.7, respectively. The cumulative incidence of SMN at 30 years was 13.9% for the AYA group. The most common SMNs in AYAs were breast cancer, gastrointestinal cancer, genital cancers, and melanoma. AYAs who had received radiation therapy had a higher cumulative incidence of SMN.CONCLUSIONS: AYAs who survive cancer for more than 5 years have a higher relative risk of SMN compared with the general population and have a higher absolute risk of SMN compared with younger or older cancer survivors. Cancer 2016;122:116–123. © 2015 American Cancer Society.Keywords
This publication has 24 references indexed in Scilit:
- Risk of Late Mortality and Second Malignant Neoplasms among 5-Year Survivors of Young Adult Cancer: A Report of the Childhood, Adolescent, and Young Adult Cancer Survivors Research ProgramJournal of Cancer Epidemiology, 2012
- Hereditary cancer risk assessment in a pediatric oncology follow‐up clinicPediatric Blood & Cancer, 2011
- Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaNature Medicine, 2011
- Starting an Adolescent and Young Adult Program: Some Success Stories and Some Obstacles to OvercomeJournal of Clinical Oncology, 2010
- Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2010
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study CohortJournal of Clinical Oncology, 2009
- Risk of a second malignant neoplasm among 5‐year survivors of cancer in childhood and adolescence in British Columbia, CanadaPediatric Blood & Cancer, 2007
- The risk of secondary malignancies over 30 years after the treatment of non‐hodgkin lymphomaCancer, 2006
- Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999